The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes
Open accessAbstract
Treatment-induced neuropathy in diabetes (also referred to as insulin neuritis) is considered a rare iatrogenic small fibre neuropathy caused by an abrupt improvement in glycaemic control in the setting of chronic hyperglycaemia. The prevalence and risk factors of this disorder are not known. In a retrospective review of all individuals referred to a tertiary care diabetic neuropathy clinic over 5 years, we define the proportion of individuals that present with and the risk factors for development of treatment-induced neuropathy in diabetes. Nine hundred and fifty-four individuals were evaluated for a possible diabetic neuropathy. Treatment-induced neuropathy in diabetes was defined as the acute onset of neuropathic pain and/or autonomic dysfunction within 8 weeks of a large improvement in glycaemic control-specified as a decrease in glycosylated haemoglobin A1C (HbA1c) of ≥2% points over 3 months. Detailed structured neurologic examinations, glucose control logs, pain scores, autonomic symptoms and other microvascular complications were measured every 3-6 months for the duration of follow-up. Of 954 patients evaluated for diabetic neuropathy, 104/954 subjects (10.9%) met criteria for treatment-induced neuropathy in diabetes with an acute increase in neuropathic or autonomic symptoms or signs coinciding with a substantial decrease in HbA1c. Individuals with a decrease in HbA1c had a much greater risk of developing a painful or autonomic neuropathy than those individuals with no change in HbA1c (P < 0.001), but also had a higher risk of developing retinopathy (P < 0.001) and microalbuminuria (P < 0.001). There was a strong correlation between the magnitude of decrease in HbA1c, the severity of neuropathic pain (R = 0.84, P < 0.001), the degree of parasympathetic dysfunction (R = -0.52, P < 0.01) and impairment of sympathetic adrenergic function as measured by fall in blood pressure on tilt-table testing (R = -0.63, P < 0.001). With a decrease in HbA1c of 2-3% points over 3 months there was a 20% absolute risk of developing treatment-induced neuropathy in diabetes, with a decrease in HbA1c of >4% points over 3 months the absolute risk of developing treatment-induced neuropathy in diabetes exceeded 80%. Treatment-induced neuropathy of diabetes is an underestimated iatrogenic disorder associated with diffuse microvascular complications. Rapid glycaemic change in patients with uncontrolled diabetes increases the risk of this complication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690
Self-citationThe Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes
Davies, M., Brophy, S., Williams, R., & Taylor, A. (2006) · Diabetes Care · doi:10.2337/dc05-2228 · Cited by 746
Early Worsening of Diabetic Retinopathy in the Diabetes Control and Complications Trial
(1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.7.874 · Cited by 509
Tesfaye, S., Vileikyte, L., Rayman, G., Sindrup, S. H., Perkins, B. A., Baconja, M., Vinik, A. I., Boulton, A. J. M., & Neuropathy, O. B. O. T. T. E. P. O. D. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1225 · Cited by 410
Albers, J. W., Herman, W. H., Pop-Busui, R., Feldman, E. L., Martin, C. L., Cleary, P. A., Waberski, B. H., Lachin, J. M., & for the DCCT/EDIC Research Group (2010) · Diabetes Care · doi:10.2337/dc09-1941 · Cited by 401
Painful Diabetic Neuropathy: Epidemiology, Natural History, Early Diagnosis, and Treatment Options
Veves, A., Backonja, M., & Malik, R. A. (2008) · Pain Medicine · doi:10.1111/j.1526-4637.2007.00347.x · Cited by 375
Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion
Martin, C. L., Albers, J., Herman, W. H., Cleary, P., Waberski, B., Greene, D. A., Stevens, M. J., & Feldman, E. L. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1549 · Cited by 350
The natural history of acute painful neuropathy in diabetes mellitus.
Archer, A. G., Watkins, P. J., Thomas, P. K., Sharma, A. K., & Payan, J. (1983) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.46.6.491 · Cited by 342
A controlled study of peripheral neuropathy after bariatric surgery
Thaisetthawatkul, P., Collazo-Clavell, M. L., Sarr, M. G., Norell, J. E., & Dyck, P. J. B. (2004) · Neurology · doi:10.1212/01.wnl.0000142038.43946.06 · Cited by 280
Neurologic complications of gastric bypass surgery for morbid obesity
Juhasz-Pocsine, K., Rudnicki, S. A., Archer, R. L., & Harik, S. I. (2007) · Neurology · doi:10.1212/01.wnl.0000262768.40174.33 · Cited by 256
Ziegler, D., Rathmann, W., Dickhaus, T., Meisinger, C., & Mielck, A. (2009) · Pain Medicine · doi:10.1111/j.1526-4637.2008.00555.x · Cited by 249
Neurologic complications after surgery for obesity
Koffman, B. M., Greenfield, L. J., Ali, I. I., & Pirzada, N. A. (2006) · Muscle & Nerve · doi:10.1002/mus.20394 · Cited by 234
The DCCT Research Group (1988) · Diabetes · doi:10.2337/diab.37.4.476 · Cited by 229
Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs
Freeman, R., Baron, R., Bouhassira, D., Cabrera, J., & Emir, B. (2014) · Pain · doi:10.1016/j.pain.2013.10.023 · Cited by 214
Self-citationTreatment-induced diabetic neuropathy: A reversible painful autonomic neuropathy
Gibbons, C. H., & Freeman, R. (2010) · Annals of Neurology · doi:10.1002/ana.21952 · Cited by 213 · cited 11×
“Most patients with TIND had rapid progression of retinopathy that developed in conjunction with the onset of neuropathic pain as previously reported (Gibbons and Freeman, 2010).”
BackgroundMethodResultInfluentialSelf-citationProinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects
Razavi Nematollahi, L., Kitabchi, A. E., Stentz, F. B., Wan, J. Y., Larijani, B. A., Tehrani, M. M., Gozashti, M. H., Omidfar, K., & Taheri, E. (2009) · Metabolism · doi:10.1016/j.metabol.2008.10.018 · Cited by 210
Tesfaye, S., Malik, R., Harris, N., Jakubowski, J. J., Mody, C., Rennie, I. G., & Ward, J. D. (1996) · Diabetologia · doi:10.1007/bf00418349 · Cited by 208
Steel, J. M., Young, R. J., Lloyd, G. G., & Clarke, B. F. (1987) · BMJ · doi:10.1136/bmj.294.6576.859 · Cited by 192
Ellenberg, M. (1974) · Diabetes · doi:10.2337/diab.23.5.418 · Cited by 191
NIS-LL: The Primary Measurement Scale for Clinical Trial Endpoints in Diabetic Peripheral Neuropathy
Bril, V. (1999) · European Neurology · doi:10.1159/000052074 · Cited by 147
Takii, M., Uchigata, Y., Tokunaga, S., Amemiya, N., Kinukawa, N., Nozaki, T., Iwamoto, Y., & Kubo, C. (2007) · International Journal of Eating Disorders · doi:10.1002/eat.20498 · Cited by 106
Structural and Functional Small Fiber Abnormalities in the Neuropathic Postural Tachycardia Syndrome
Gibbons, C. H., Bonyhay, I., Benson, A., Wang, N., & Freeman, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084716 · Cited by 99 · cited 2×
“symptoms and 10 = most severe symptoms) as previously described (Gibbons and Freeman, 2010; Gibbons et al., 2013).”
MethodSelf-citationInsulin neuritis. A case report.
Caravati, C. M. (1933) · Medical Entomology and Zoology · Cited by 85
Young, R. J., Ewing, D. J., & Clarke, B. F. (1988) · Diabetes Care · doi:10.2337/diacare.11.1.34 · Cited by 75
Hypoglycemia increases serum interleukin-6 levels in healthy men and women
Dotson, S., Freeman, R., Failing, H. J., & Adler, G. K. (2008) · Diabetes Care · doi:10.2337/dc07-2243 · Cited by 70
Self-citationDyck, P. J. B., Melton, L. J., O’Brien, P. C., & Service, F. J. (1997) · Diabetes · doi:10.2337/diab.46.2.s5 · Cited by 64
Acute painful neuropathy induced by rapid correction of serum glucose levels in diabetic patients
Dabby, R., Sadeh, M., Lampl, Y., Gilad, R., & Watemberg, N. M. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.08.011 · Cited by 61
Acute glucose deprivation leads to apoptosis in a cell model of acute diabetic neuropathy
Honma, H., Podratz, J. L., & Windebank, A. A. J. (2003) · Journal of the Peripheral Nervous System · doi:10.1046/j.1529-8027.2003.03009.x · Cited by 42
Experimental hypoglycemia is a human model of stress-induced hyperalgesia
Gibbons, C. H., Adler, G. K., Bonyhay, I., & Freeman, R. (2012) · Pain · doi:10.1016/j.pain.2012.06.030 · Cited by 38
Self-citationOhshima, J., & Nukada, H. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02910-4 · Cited by 36
Rubino, A., Rousculp, M. D., Davis, K. H., Wang, J., Bastyr, E. J., & Tesfaye, S. H. (2007) · Primary care diabetes · doi:10.1016/j.pcd.2007.07.006 · Cited by 35
Dengler, R., Wohlfarth, K., Zierz, S., J�bges, M., & Schubert, M. (1996) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199604)19:4<463::aid-mus6>3.0.co;2-a · Cited by 34
DIABETIC NEUROPATHY PRECIPITATING AFTER INSTITUTION OF DIABETIC CONTROL
Ellenberg, M. (1958) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195810000-00008 · Cited by 33
Chantelau, E. A., & Meyer-Schwickerath, R. (2003) · Ophthalmologica · doi:10.1159/000071355 · Cited by 30
Chantelau, E. A., Meyer-Schwickerath, R., & Klabe, K. (2009) · Ophthalmologica · doi:10.1159/000260231 · Cited by 19
Acute painful diabetic neuropathy: two patients with recent insulin-dependent diabetes mellitus.
Vital, C., Vital, A., Dupon, M., Gin, H., Rouanet‐Larrivière, M., & Lacut, J. Y. (1997) · PubMed · Cited by 12
Leow, M. K., & Wyckoff, J. (2005) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2005.00051.x · Cited by 6
Cited by
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602
Self-citationNeuropathic Pain: From Mechanisms to Treatment
Finnerup, N. B., Kuner, R., & Jensen, T. S. (2021) · Physiological Reviews · doi:10.1152/physrev.00045.2019 · Cited by 1,558
Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes
Hicks, C. W., & Selvin, E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1212-8 · Cited by 798
Camilleri, M., Chedid, V., Ford, A. C., Haruma, K., Horowitz, M., Jones, K. L., Low, P. A., Park, S.-Y., Parkman, H. P., & Stanghellini, V. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0038-z · Cited by 411
Challenges of neuropathic pain: focus on diabetic neuropathy
Rosenberger, D. C., Blechschmidt, V., Timmerman, H., Wolff, A., & Treede, R.-D. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02145-7 · Cited by 325
Metadata
- Authors
- Gibbons, C. H., & Freeman, R.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-11-10
- Volume
- 138
- Issue
- 1
- Pages
- 43-52
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2154974174
- Cited by
- 282
- References
- 39
- FWCI
- 9.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.